Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2021 2
2022 2
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19.
Stanevich OV, Alekseeva EI, Sergeeva M, Fadeev AV, Komissarova KS, Ivanova AA, Simakova TS, Vasilyev KA, Shurygina AP, Stukova MA, Safina KR, Nabieva ER, Garushyants SK, Klink GV, Bakin EA, Zabutova JV, Kholodnaia AN, Lukina OV, Skorokhod IA, Ryabchikova VV, Medvedeva NV, Lioznov DA, Danilenko DM, Chudakov DM, Komissarov AB, Bazykin GA. Stanevich OV, et al. Among authors: stukova ma. Nat Commun. 2023 Jan 10;14(1):149. doi: 10.1038/s41467-022-34033-x. Nat Commun. 2023. PMID: 36627290 Free PMC article.
Bivalent omicron (BA.1) booster vaccination against SARS-CoV-2.
Vasin AV, Stukova MA. Vasin AV, et al. Among authors: stukova ma. Lancet Infect Dis. 2023 Aug;23(8):880-881. doi: 10.1016/S1473-3099(23)00189-5. Epub 2023 Apr 21. Lancet Infect Dis. 2023. PMID: 37088097 Free PMC article. No abstract available.
SARS-CoV-2 Subunit Virus-like Vaccine Demonstrates High Safety Profile and Protective Efficacy: Preclinical Study.
Vakhrusheva AV, Kudriavtsev AV, Kryuchkov NA, Deev RV, Frolova ME, Blagodatskikh KA, Djonovic M, Nedorubov AA, Odintsova E, Ivanov AV, Romanovskaya-Romanko EA, Stukova MA, Isaev AA, Krasilnikov IV. Vakhrusheva AV, et al. Among authors: stukova ma. Vaccines (Basel). 2022 Aug 10;10(8):1290. doi: 10.3390/vaccines10081290. Vaccines (Basel). 2022. PMID: 36016181 Free PMC article.
Mucosal Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens Provides Protection against Mycobacterium tuberculosis in Mice and Guinea Pigs.
Sergeeva M, Romanovskaya-Romanko E, Zabolotnyh N, Pulkina A, Vasilyev K, Shurigina AP, Buzitskaya J, Zabrodskaya Y, Fadeev A, Vasin A, Vinogradova TI, Stukova MA. Sergeeva M, et al. Among authors: stukova ma. Vaccines (Basel). 2021 Apr 16;9(4):394. doi: 10.3390/vaccines9040394. Vaccines (Basel). 2021. PMID: 33923548 Free PMC article.
Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial.
Kudriavtsev AV, Vakhrusheva AV, Kryuchkov NA, Frolova ME, Blagodatskikh KA, Ivanishin TV, Djonovic M, Romanovskaya-Romanko EA, Kovalenko AN, Lioznov DA, Zubkova TG, Teplykh SV, Oseshnyuk RA, Stukova MA, Isaev AA, Krasilnikov IV. Kudriavtsev AV, et al. Among authors: stukova ma. Vaccines (Basel). 2023 Feb 1;11(2):326. doi: 10.3390/vaccines11020326. Vaccines (Basel). 2023. PMID: 36851204 Free PMC article.
Enhancement of the Local CD8+ T-Cellular Immune Response to Mycobacterium tuberculosis in BCG-Primed Mice after Intranasal Administration of Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens.
Vasilyev K, Shurygina AP, Zabolotnykh N, Sergeeva M, Romanovskaya-Romanko E, Pulkina A, Buzitskaya J, Dogonadze MZ, Vinogradova TI, Stukova MA. Vasilyev K, et al. Among authors: stukova ma. Vaccines (Basel). 2021 Nov 3;9(11):1273. doi: 10.3390/vaccines9111273. Vaccines (Basel). 2021. PMID: 34835204 Free PMC article.
An inactivated, adjuvanted whole virion clade 2.2 H5N1 (A/Chicken/Astana/6/05) influenza vaccine is safe and immunogenic in a single dose in humans.
Sansyzbay AR, Erofeeva MK, Khairullin BM, Sandybayev NT, Kydyrbayev ZK, Mamadaliyev SM, Kassenov MM, Sergeeva MV, Romanova JR, Krivitskaya VZ, Kiselev OI, Stukova MA. Sansyzbay AR, et al. Among authors: stukova ma. Clin Vaccine Immunol. 2013 Aug;20(8):1314-9. doi: 10.1128/CVI.00096-13. Epub 2013 Jun 26. Clin Vaccine Immunol. 2013. PMID: 23803900 Free PMC article. Clinical Trial.